Project Grant R01AG082975

Award Date 8/1/24
Completion Date 5/31/29
Dollars Obligated $2.4M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $161,500.00 to investigate the role of perineuronal nets (PNN) in the development of postoperative delirium in aged mice. The research aims to test the hypothesis that changes in PNN and parvalbumin-positive neurons coincide with delirium-like cognitive impairment in aged mice subjected to anesthesia, surgery, and intensive care unit (ICU)-like conditions. The project will also examine whether...
This Project Grant award of $5,554,915.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research at The Leland Stanford Junior University to investigate the role of epigenetics in the pathogenesis of post-operative delirium (POD) and its relationship to long-term cognitive decline in elderly patients with dementia. The research aims to identify potential biomarkers associated with the risk of POD and subsequent patient outcomes like post-operative cognitive decline...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop a proteomic signature for predicting postoperative delirium and long-term cognitive decline in older cardiac surgery patients. The $1,631,690 award will leverage plasma samples from the ongoing PANDORA trial to: Derive and validate a delirium protein signature using state-of-the-art proteomics (Aim 1). The top 10 proteins will be independently validated across all 450 placebo group...
The National Institute on Aging (NIA) awarded a $444,125 Project Grant (CFDA 93.866 - Aging Research) to the University of Virginia (UVA) to study the use of exhaled volatile organic compounds (VOCs) and Alzheimer's disease (AD)-related blood biomarkers to predict postoperative delirium (POD) in elderly patients undergoing spine surgery. The research aims to determine if a non-invasive analysis of exhaled VOCs can be used to predict POD, and to investigate the relationship between exhaled VOCs...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $299,893 to Pascall Systems, Inc. to develop a novel system that combines pre-operative cognitive assessment with Pascall's FDA-cleared wireless EEG technology for intraoperative monitoring. The goal is to enable personalized anesthesia care and effective monitoring of postoperative neurocognitive disorders (PNDs) in elderly surgical patients. The key products and services to be delivered...
This Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, provides $715,801 to Duke University to investigate the causal role of blood-brain barrier dysfunction and neuroinflammation in exacerbating postoperative delirium and subsequent onset of Alzheimer's disease and related dementias in aging and hypertension. The overarching goal is to elucidate how hypertension primes the neurovascular unit and worsens delirium-like behavior after orthopedic...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $805,295 to The Leland Stanford Junior University to conduct a study examining cerebrospinal fluid (CSF) and blood biomarkers to gain insight into postoperative delirium and neurocognitive dysfunction. The 5-year study will enroll 180 patients undergoing aortic surgery, collecting serial CSF and blood samples to determine if biomarkers related to blood-brain barrier injury, inflammation,...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), provides $412,500.00 to the University of South Florida to investigate changes in the brain extracellular matrix (ECM) during normal aging and in Alzheimer's disease (AD). The key objectives are to: 1) determine ECM composition changes in different mouse brain regions at various ages, 2) examine ECM alterations in two mouse models of AD, and 3) explore ECM...
This Project Grant from the National Institutes of Health National Institute on Aging provides $4,489,362 to Duke University from September 15, 2022 through August 31, 2025 under the Aging Research program (CFDA 93.866). The grant will fund research to identify mechanisms of blood-brain barrier dysfunction in delirium superimposed on dementia after surgery. Specifically, the researchers will characterize how the postoperative systemic environment impacts the blood-brain barrier using...
This $2,356,117 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research to improve the perioperative management of patients with Alzheimer's disease and related dementias. The primary objectives are to: (1) identify the extent to which surgical patients with these conditions are at increased risk for adverse postoperative outcomes, and (2) estimate the association between various perioperative interventions and the incidence...

NEUROINFLAMMATION, PERINEURAL NETS, AND POSTOPERATIVE DELIRIUM - THE AGING BRAIN IS ASSOCIATED WITH AN INCREASED RISK OF DEVELOPING POSTOPERATIVE DELIRIUM (POD), POSTOPERATIVE NEUROCOGNITIVE DISORDER (PNCD), AND ALZHEIMER'S DISEASE. POD OCCURS IN 9-50% OF OLDER PATIENTS UNDERGOING ANESTHESIA AND SURGERY AND IS ASSOCIATED WITH A HIGH RISK OF DEVELOPING ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD), GREATER INCIDENCES OF POSTOPERATIVE COMPLICATIONS, WORSE CLINICAL OUTCOMES, AND HIGHER MORTALITY. HEIGHTENED NEUROINFLAMMATION IS ONE OF THE KEY DRIVERS UNDERLYING AGE-RELATED POD. EXISTING RESEARCH ON POD PRIMARILY FOCUSES ON GLIAL CELLS AND NEURONS, WITH LITTLE ATTENTION PAID TO THE EXTRACELLULAR MATRIX(ECM). CELLS IN THE BODY CONSTANTLY COMMUNICATE WITH OTHER CELLS AND WITH ECM. IT HAS BECOME INCREASINGLY RECOGNIZED THAT ECM PROVIDES NOT ONLY ESSENTIAL PHYSICAL SCAFFOLDING FOR THE CELLULAR CONSTITUENTS BUT ALSO INITIATES CRUCIAL BIOCHEMICAL AND BIOMECHANICAL CUES THAT ARE OF UTMOST FUNCTIONAL IMPORTANCE. HOWEVER, WHETHER ECM IS IMPLICATED IN POD HAS YET TO BE EXAMINED. PERINEURAL NETS (PNNS) ARE ECM WITH CHONDROITIN SULFATE PROTEOGLYCAN-CONTAINING STRUCTURES SURROUNDING THE SOMA AND DENDRITES OF VARIOUS TYPES OF MAMMALIAN NEURONS. WE FOUND THAT OLDER MICE DISPLAYED ACCENTUATED NEUROINFLAMMATION CHARACTERIZED BY INCREASED IBA-1 EXPRESSION AS WELL AS DECREASED PNNS USING WFA STAINING. MICROGLIA DEPLETION USING PLX3397 PREVENTED THE DEGRADATION OF PNNS AND DETERRED THE OCCURRENCE OF POD, SUGGESTING MICROGLIA-MEDIATED PNNS DEGRADATION AS A NEUROINFLAMMATION MECHANISM UNDERLYING POD. TO DIRECTLY INTERROGATE NEURONAL ACTIVITIES IN POD, WE ESTABLISHED INTRAVITAL MULTI-PHOTON MICROSCOPY IN THE HIPPOCAMPUS. OLDER MICE AFTER ANESTHESIA AND SURGERY DEMONSTRATED EXAGGERATED EXCITATORY NEURON ACTIVITIES. IN CONTRAST, PARVALBUMIN (PV) INTERNEURONS, A KEY SUBTYPE OF INHIBITORY NEURONS WHICH ARE OFTEN SURROUNDED BY PNNS, DISPLAYED DECREASED NEURONAL ACTIVITIES IN OLDER MICE AFTER ANESTHESIA AND SURGERY, REVEALING EXCITATORY/INHIBITORY IMBALANCE LINKED TO POD. BASED ON THESE RESULTS, WE HYPOTHESIZE THAT NEUROINFLAMMATION ACCOMPANIED BY ANESTHESIA AND SURGERY PROMOTES PNNS DEGRADATION WHICH LEADS TO NEURONAL DYSFUNCTION AND AGE-RELATED POD DEVELOPMENT. WE PLAN TO CARRY OUT THREE INTERRELATED BUT NOT INTERDEPENDENT AIMS TO RIGOROUSLY TEST THIS HYPOTHESIS. AIM 1: TO INVESTIGATE THE KINETICS OF NEUROINFLAMMATION-MEDIATED PNNS DEGRADATION AFTER ANESTHESIA AND SURGERY. AIM 2: TO EXAMINE IF DEPLETING PNNS SURROUNDING PV INTERNEURONS COULD PRECIPITATE POD. AIM 3: TO PREVENT POD BY ATTENUATING NEUROINFLAMMATION-INDUCED PNNS DEGRADATION. TAKEN TOGETHER, THIS PROPOSAL USES MULTIDISCIPLINARY TOOLS INCLUDING INTRAVITAL MULTI-PHOTON IMAGING, GENETIC MANIPULATION (MICROGLIA DEPLETION, NEURON-SPECIFIC CHABC, HAPLN1 EXPRESSION, ETC.), BIOCHEMISTRY, AND ANIMAL BEHAVIOR, TO DISSECT A PREVIOUSLY UNKNOWN ROLE FOR PNNS (ECM) IN THE PATHOGENESIS OF POD, WHICH PROVIDES NOVEL MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETS FOR POD, A CONDITION RELATED TO ADRD.

Posted 7/31/24, 12:00 AM